Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Northern Indiana Cancer Research Consortium (NICRC) is a community-based clinical research organization that provides access to National Cancer Institute (NCI) sponsored clinical trials. Operating as a member of the NCI Community Oncology Research Program (NCORP), the consortium partners with regional healthcare systems including Beacon Health System and Goshen Health. NICRC focuses on a broad spectrum of oncology research, including cancer prevention, screening, treatment, and cancer care delivery. By facilitating these trials, the organization allows patients in Northern Indiana and Southwestern Michigan to access innovative therapies without traveling to major academic centers. The consortium plays a vital role in advancing evidence-based cancer care through its robust infrastructure for clinical trial management and patient enrollment. It serves as a critical link between federal research initiatives and community-level healthcare delivery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Northern Indiana Cancer Research Consortium.